Vaxart Inc (VXRT)
0.71
0.00 (0.00%)
USD |
NASDAQ |
Apr 25, 10:21
Vaxart 1 Year Total Returns (Daily): -0.91% for April 24, 2024
1 Year Total Returns (Daily) Chart
Historical 1 Year Total Returns (Daily) Data
Date | Value |
---|---|
April 24, 2024 | -0.91% |
April 23, 2024 | 5.25% |
April 22, 2024 | 7.67% |
April 19, 2024 | 5.09% |
April 18, 2024 | 21.79% |
April 17, 2024 | 25.00% |
April 16, 2024 | 36.13% |
April 15, 2024 | 38.37% |
April 12, 2024 | 52.93% |
April 11, 2024 | 70.80% |
April 10, 2024 | 60.83% |
April 09, 2024 | 41.21% |
April 08, 2024 | 46.64% |
April 05, 2024 | 45.12% |
April 04, 2024 | 55.65% |
April 03, 2024 | 62.55% |
April 02, 2024 | 63.87% |
April 01, 2024 | 71.80% |
March 28, 2024 | 73.29% |
March 27, 2024 | 69.74% |
March 26, 2024 | 61.08% |
March 25, 2024 | 62.40% |
March 22, 2024 | 70.39% |
March 21, 2024 | 64.61% |
March 20, 2024 | 74.77% |
Date | Value |
---|---|
March 19, 2024 | 49.31% |
March 18, 2024 | 49.31% |
March 15, 2024 | 42.09% |
March 14, 2024 | 39.24% |
March 13, 2024 | 41.20% |
March 12, 2024 | 49.63% |
March 11, 2024 | 50.94% |
March 08, 2024 | 45.96% |
March 07, 2024 | 33.14% |
March 06, 2024 | 48.88% |
March 05, 2024 | 38.65% |
March 04, 2024 | 40.37% |
March 01, 2024 | 61.39% |
February 29, 2024 | 56.53% |
February 28, 2024 | 66.15% |
February 27, 2024 | 62.82% |
February 26, 2024 | 52.42% |
February 23, 2024 | 44.94% |
February 22, 2024 | 52.99% |
February 21, 2024 | 49.84% |
February 20, 2024 | 24.18% |
February 16, 2024 | 21.72% |
February 15, 2024 | 20.77% |
February 14, 2024 | 25.89% |
February 13, 2024 | 30.77% |
Total Return Definition
The Total return is the change in price over a specific period of time that includes dividends and distributions paid.
1 Year Total Returns (Daily) Range, Past 5 Years
-93.48%
Minimum
Oct 04 2019
2.58K%
Maximum
Dec 21 2020
186.4%
Average
-41.85%
Median
Jul 06 2022
1 Year Total Returns (Daily) Benchmarks
Novavax Inc | -48.64% |
aTyr Pharma Inc | -25.58% |
Allogene Therapeutics Inc | -43.39% |
AIM ImmunoTech Inc | -20.37% |
Protalix BioTherapeutics Inc | -49.79% |